Adiponectin has shown to negatively correlate with highly sensitive CRP in patients with diabetes and was also shown to inversely correlate with CRP levels following the BNT162b2 vaccine in SARS-CoV-2 infected individuals [20,37]. Here, ADIPOQ is linked to diabetes mellitus.